Experimental drug NU-9 shows promise in clearing toxic proteins associated with neurodegenerative diseases. Scientists tested NU-9 in a pre-symptomatic animal model of Alzheimer’s disease. Drug ...

Although the injectable forms of the popular GLP-1 drugs are more effective, the pills under development are both easier to ...

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A new experimental drug from ...

STP-30 will operate the first-ever DiskSats, a new type of spacecraft developed by The Aerospace Corporation with funding ...

Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

Dec 15 () - Shares of French pharmaceutical group Sanofi fell 4% on Monday after it flagged another delay to ​a U. regulatory ...

The government is launching a mobile app to streamline urea booking for farmers, reducing wait times and enhancing ...

Sanofi said a U.S. regulatory decision on its tolebrutinib experimental treatment for a type of multiple sclerosis would be delayed again, and that a late-stage trial for a different form of the ...

Zhengyang Du is an independent and avant-garde director and cinematographer. His work spans documentary and narrative films, ...

Former National Basketball Association (NBA) centre Jason Collins is undergoing experimental chemotherapy treatment in ...

An experimental vaccine targeting aggressive triple-negative breast cancer (TNBC) has shown encouraging early results in clinical trials. The vaccine ...